LVTX - LAVA Therapeutics NV

QQQ $ 636.54 $ 0.99 (0.16 %)

DIA $ 479.48 $ 0.92 (0.19 %)

SPY $ 688.92 $ 0.16 (0.02 %)

TLT $ 91.73 $ -0.15 (-0.16 %)

GLD $ 369.70 $ 0.09 (0.02 %)

Previous Close

$ 1.61

Open

$ 1.61

Bid

$ 1.57 x 4,700

Ask

$ 1.63 x 2,000

Day's Range

$ 1.60 - $ 1.60

52 Week Range

$ 0.85 - $ 2.01

Volume

13,760

Average Volume

Market Cap

42.35M

Beta (5Y Monthly)

$ 0.51

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-13-2025	06-30-2025	10-Q
2	05-14-2025	03-31-2025	10-Q
3	03-28-2025	12-31-2024	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

XOMA and LAVA Therapeutics Announce Amendm...
10/17/2025 15:48:30

- Amendment includes finalized cash amount and updated CVR terms for tender offer- LAVA announces new date for extraordinary ge...

XOMA Royalty And LAVA Therapeutics Announc...
10/02/2025 20:47:45

EMERYVILLE, Calif. and UTRECHT, The Netherlands and PHILADELPHIA, Oct. 02, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (&...

4-biotech-stocks-that-are-showing-weakness-momentum-scores-fading-over-the-past-week

4 Biotech Stocks That Are Showing Weakness...
09/03/2025 10:21:00

Several biotech stocks have seen their strength fade over the past week, with their Momentum scores in Benzinga's Edge Stoc...

LAVA Therapeutics Q2 EPS $(0.32) Misses $(...
08/13/2025 20:57:19

HC Wainwright & Co. Maintains Neutral on L...
08/05/2025 16:23:29

HC Wainwright & Co. analyst Arthur He maintains LAVA Therapeutics (NASDAQ:LVTX) with a Neutral and lowers the price targ...

this-block-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-tuesday

This Block Analyst Is No Longer Bullish; H...
08/05/2025 13:11:05

Jefferies Downgrades LAVA Therapeutics to ...
08/05/2025 10:43:39

Jefferies analyst Roger Song downgrades LAVA Therapeutics (NASDAQ:LVTX) from Buy to Hold and lowers the price target from $3...

Trading Halt: Halt status updated at 7:55:...
08/04/2025 11:55:06

XOMA Royalty To Acquire Lava Therapeutics ...
08/04/2025 11:34:03

Trading Halt: Halted at 7:25:00 a.m. ET - ...
08/04/2025 11:25:04

JMP Securities Reiterates Market Perform o...
05/15/2025 14:08:41

JMP Securities analyst Reni Benjamin reiterates LAVA Therapeutics (NASDAQ:LVTX) from Market Perform to Market Perform.

LAVA Therapeutics Q1 EPS $(0.13) Beats $(0...
05/14/2025 11:40:29

LAVA Therapeutics (NASDAQ:LVTX) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0...

LAVA Therapeutics Announced That The Nethe...
04/16/2025 11:33:54

HC Wainwright & Co. Reiterates Neutral on ...
03/31/2025 10:48:09

HC Wainwright & Co. analyst Arthur He reiterates LAVA Therapeutics (NASDAQ:LVTX) with a Neutral and maintains $1.5 price...

LAVA Therapeutics Reports Q4 Revenues Of $...
03/28/2025 11:42:19

LAVA Therapeutics Receives Nasdaq Non-Comp...
02/28/2025 21:13:56

analyst-downgrades-lava-therapeutics-sees-pipeline-overhang

Analyst Downgrades LAVA Therapeutics, Sees...
02/28/2025 17:32:15

LAVA Therapeutics reviews strategic options amid cost cuts. HC Wainwright downgrades stock, citing uncertainties over LAVA-1266...

this-constellation-brands-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-thursday

This Constellation Brands Analyst Is No Lo...
02/27/2025 17:58:13

HC Wainwright & Co. Downgrades LAVA Therap...
02/27/2025 13:53:05

HC Wainwright & Co. analyst Arthur He downgrades LAVA Therapeutics (NASDAQ:LVTX) from Buy to Neutral and lowers the pric...

LAVA Initiates Process To Review Strategic...
02/25/2025 12:33:01